Liru Wang

Title: Liru Wang: Innovator in Drug Synthesis

Introduction

Liru Wang is a notable inventor based in Beijing, China. He has made significant contributions to the field of drug synthesis, particularly with his innovative methods for preparing pharmaceuticals. His work is characterized by a focus on improving the quality and yield of drug products.

Latest Patents

Liru Wang holds a patent for a method of preparing lornoxicam. This method involves using specific raw materials, including 6-chloro-4-hydroxy-2-methyl-2-H-thieno[2,3-e]-1,2-thiazine methyl carboxylate-1,1-dioxide and 2-aminopyridine, along with xylene as a solvent. The process includes mixing the raw materials and solvent, adding a stabilizer, and subjecting the mixture to ammonolysis. The resulting reactant is cooled, and the solvent is removed through vacuum concentration. An organic solvent is then added, and the mixture is filtered to obtain crude lornoxicam, which is subsequently refined to yield the final product. The use of p-toluenesulfonic acid as a stabilizer is a key aspect of this method, as it helps to reduce the reaction temperature and enhance the overall reaction efficiency.

Career Highlights

Liru Wang is currently employed at Beijing Jincheng Taier Pharmaceutical Co., Ltd. His role at the company allows him to apply his expertise in drug synthesis and contribute to the development of new pharmaceutical products. His innovative approach has garnered attention in the industry, showcasing his commitment to advancing drug synthesis techniques.

Collaborations

Liru Wang collaborates with talented colleagues, including Zhen Liu and Dongye Xing. Their combined efforts in research and development have led to advancements in pharmaceutical synthesis and innovation.

Conclusion

Liru Wang is a distinguished inventor whose work in drug synthesis has made a significant impact in the pharmaceutical industry. His innovative methods and dedication to improving drug quality and yield highlight his contributions to the field.